ReviewDrug design, development and therapy2010
Optimal use of recombinant factor VIIa in the control of bleeding episodes in hemophilic patients.
John PuetzPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it